| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adenocarcinoma Harboring EGFR-RAD51 Fusion Treated With Osimertinib: A Case Report
|
Lai, Sunny Y.
|
|
|
5 |
4 |
p.
|
article
|
| 2 |
Brief Report: Clinical Outcomes by Infusion Timing of Immune Checkpoint Inhibitors in Patients With Locally Advanced NSCLC
|
Hirata, Tsuyoshi
|
|
|
5 |
4 |
p.
|
article
|
| 3 |
Brief Report: Risk of Recurrent Interstitial Lung Disease From Osimertinib Versus Erlotinib Rechallenge After Symptomatic Osimertinib-Induced Interstitial Lung Disease
|
Li, Molly S.C.
|
|
|
5 |
4 |
p.
|
article
|
| 4 |
Cabozantinib Response in a Patient With NSCLC Harboring Both MET Exon 14 Skipping Mutation and Secondary RET Fusion: A Case Report
|
Torrado, Carlos
|
|
|
5 |
4 |
p.
|
article
|
| 5 |
Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315)
|
Griesinger, Frank
|
|
|
5 |
4 |
p.
|
article
|
| 6 |
Heart and Lung Dose as Predictors of Overall Survival in Patients With Locally Advanced Lung Cancer. A National Multicenter Study
|
Olloni, Agon
|
|
|
5 |
4 |
p.
|
article
|
| 7 |
Immunotherapy With Radiotherapy for Brain Metastases in Patients With NSCLC: NEJ060
|
Tozuka, Takehiro
|
|
|
5 |
4 |
p.
|
article
|
| 8 |
Improving Lung Cancer Screening Selection: The HUNT Lung Cancer Risk Model for Ever-Smokers Versus the NELSON and 2021 United States Preventive Services Task Force Criteria in the Cohort of Norway: A Population-Based Prospective Study
|
Nguyen, Olav Toai Duc
|
|
|
5 |
4 |
p.
|
article
|
| 9 |
Osimertinib Plasma Trough Concentration in Relation to Brain Metastases Development in Patients With Advanced EGFR-Mutated NSCLC
|
Gulikers, Judith L.
|
|
|
5 |
4 |
p.
|
article
|
| 10 |
Phosphoproteomic Analysis Identified Mutual Phosphorylation of FAK and Src as a Mechanism of Osimertinib Resistance in EGFR-Mutant Lung Cancer
|
Tozuka, Takehiro
|
|
|
5 |
4 |
p.
|
article
|
| 11 |
Prolonged Cancer Control With Adagrasib in Patients With Metastatic, KRAS G12C -Mutated NSCLC After Sotorasib-Induced Hepatotoxicity: A Case Report
|
Stratton, Natalie
|
|
|
5 |
4 |
p.
|
article
|
| 12 |
Rapid Response to Lenvatinib and Disease Flare After Discontinuation in a Patient With Thymic Carcinoma Harboring KIT Exon 11 Mutation: A Case Report
|
Torasawa, Masahiro
|
|
|
5 |
4 |
p.
|
article
|
| 13 |
RET Fusion Testing in Patients With NSCLC: The RETING Study
|
Conde, Esther
|
|
|
5 |
4 |
p.
|
article
|
| 14 |
The Tumor Immune Microenvironment Is Associated With Recurrence in Early-Stage Lung Adenocarcinoma
|
Kanemura, Hiroaki
|
|
|
5 |
4 |
p.
|
article
|
Journal description